I am amazed at the optimism on the MNKD msg board, and how the price has held up so well, as an outside opinion. I read that Adam Feustein on twitter even said someone upped the price target to $9.00 from $6.00...lol. I would find it very difficult to believe that the FDA would now rush any approval on their drug, and now we should hope that at least Bydureon is ahead in the line of approval with the FDA. Just wonder when we hear any good news about that from Amylin? And another thing, at least we do have 2 drugs on the market now!